Electroporation Potentiated Immunotherapy in Cancer
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The study is investigating the efficacy and safety of combined irreversible electroporation
(IRE) and checkpoint inhibition in metastatic pancreatic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
Collaborators:
Aalborg University Danish Cancer Society Odense University Hospital